Purple Finance Limited has successfully completed its postal ballot process on January 2, 2026, with both proposed resolutions receiving overwhelming shareholder approval. The company announced the voting results on January 5, 2026, following scrutiny by appointed scrutinizer CS Abhilasha Chaudhary of Abhilasha Chaudhary & Associates.

Postal Ballot Process and Timeline

The e-voting process commenced on December 4, 2025, at 9:00 AM IST and concluded on January 2, 2026, at 5:00 PM IST. The postal ballot notice was circulated to shareholders on December 3, 2025, in compliance with the Companies Act, 2013, and SEBI LODR Regulations, 2015.

Resolution Details and Voting Results

Both resolutions were categorized as ordinary resolutions and received strong shareholder support. The first resolution involved the regularization of Mr. Sandeep Jindal (DIN: 00402046) as Non-Executive Non-Independent Director, while the second addressed the re-classification of shareholders from "Promoter Group" category to "Public" category.

Resolution 1: Director Regularization

Resolution 2: Shareholder Reclassification

Shareholding Structure and Participation

The voting results revealed the company's shareholding composition as of the record date. Out of 54,424,212 total shares, the promoter and promoter group held 19,723,973 shares, while public institutions and non-institutions held 2,023,834 and 32,676,405 shares respectively.

The overall participation rate stood at 22.35% of outstanding shares, with 12,164,916 votes polled out of the total eligible shares. The promoter group demonstrated strong participation with 60.44% of their holdings voted, while public non-institutional shareholders showed 0.75% participation.

Regulatory Compliance and Documentation

The postal ballot process was conducted in full compliance with applicable regulations, including the Companies Act, 2013, MCA circulars, and SEBI LODR Regulations. CS Abhilasha Chaudhary (COP: 23604) served as the scrutinizer, ensuring fair and transparent voting procedures throughout the process.

The company has made the voting results and scrutinizer's report available on its website at www.purplefinance.in , maintaining transparency with stakeholders. Both resolutions are deemed passed effective January 2, 2026, marking successful completion of the corporate governance process.

Shukra Pharmaceuticals Limited announced significant board changes following its board meeting held on December 30, 2025. The meeting, which commenced at 6:30 PM and concluded at 7:10 PM, resulted in the appointment of a new Independent Director and the resignation of an existing board member, leading to comprehensive committee reconstitution.

New Director Appointment

The board approved the appointment of Mr. Dinesh Chauhan (DIN: 11456530) as Additional Director (Non-Executive Independent Director) for a three-year term effective December 30, 2025. The appointment is subject to approval by the company's members at the ensuing Annual General Meeting.

Mr. Chauhan brings over 7 years of business management expertise, with demonstrated abilities in overseeing and enhancing organizational operations. His experience includes driving performance, streamlining processes, and fostering productive work environments that support strategic goals and business growth. The company confirmed that Mr. Chauhan is not related to any existing directors on the board and is not debarred from holding directorship by SEBI or any other authority.

Director Resignation

Simultaneously, the board noted the resignation of Ms. Bhoomi Patel (DIN: 08316893) from her position as Independent Director, effective December 30, 2025. Ms. Patel cited personal reasons for her departure in her resignation letter submitted to the board.

With her resignation, Ms. Patel also ceased to be a member of the Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee. The company confirmed that she does not hold directorship in any other listed entity and is not a member of any other board committee.

Committee Reconstitution

Following these board changes, the company reconstituted its key committees with Mr. Dinesh Chauhan assuming chairperson roles across all three committees:

All committee members hold Non-Executive Independent Director positions, ensuring compliance with regulatory requirements for board committee composition.

Regulatory Compliance

The announcements were made in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company submitted the board meeting outcome to BSE Limited (Scrip Code: 524632), including detailed profiles of the appointed director and resignation letters from the departing director. All necessary statutory and regulatory compliances, including filings with the Registrar of Companies and Stock Exchange, will be completed as required under the Companies Act, 2013, SEBI (LODR) Regulations, and other applicable laws.

The board changes reflect the company's commitment to maintaining strong governance standards while ensuring continuity in its operations and strategic direction.